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ABSTRACT: Childhood obesity is a serious public health problem worldwide. Perturbations in the gut microbiota composition have been associated with the development of obesity in both children and adults. Probiotics, on the other hand, are proven to restore the composition of the
gut microbiome which helps reduce the development of obesity. However, data on the effect of probiotics on gut microbiota and its association with childhood obesity is limited. This study aims to determine the effect of probiotics supplement intervention on gut microbiota profiles
in obese and normal-weight children. A total of 37 children, 17 normal weight, and 20 overweight school children from a government school in
Selangor were selected to participate in this study. Participants were further divided into intervention and control groups. The intervention groups
received daily probiotic drinks while the control groups continued eating their typical diet. Fecal samples were collected from the participants
for DNA extraction. The hypervariable V3 and V4 regions of 16S rRNA gene were amplified and sequenced using the Illumina MiSeq platform.
No significant differences in alpha diversity were observed between normal weight and obese children in terms of the Shannon Index for evenness or species richness. However, a higher intervention effect on alpha diversity was observed among normal-weight participants compared
to obese. The participants’ microbiome was found to fluctuate throughout the study. Analysis of the taxa at species level showed an increase in
Bacteroides ovatus among the normal weight cohort. Genus-level comparison revealed a rise in genus Lachnospira and Ruminococcus in the
overweight participants after intervention, compared to the normal-weight participants. The probiotics intervention causes an alteration in gut
microbiota composition in both normal and overweight children. Though the association could not be defined statistically, this study has provided
an improved understanding of the intervention effect of probiotics on gut microbiome dysbiosis in an underrepresented population.
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Introduction

Among Malaysian ethnic groups, Chinese has the highest
obesity (13.0%), followed by Indians (12.6%) and Malays
(11.8%). Children are overweight for a variety of reasons, such
as unhealthy eating patterns, lack of physical activity, genetic
factors, or a combination of these factors.3 Childhood obesity
facilitates alteration of the gut microbiome through various
health factors such as insulin resistance and type 2 diabetes,
hyperlipidemia, hypertension, renal and liver disease, as well as
reproductive dysfunction. Modulation of the gut microbiota
among obese humans showed that the gut microbiome of
obese individuals had a decrease in the gram-positive bacterial
phyla Firmicutes and Actinobacteria.4

Overweight and obesity are global diseases affecting at least 1
in 3 adults and 1 in 5 children according to the Organization
for Economic Co-operation and Development.1 The prevalence of overweight children is approximately 22.5% and 7.9%
in Singapore and Thailand, respectively.2 In Malaysia, the
National Health and Morbidity Survey reported an 11.9%
incidence of obesity among children under 18 years old. The
highest obesity rate was found in Perak (14.1%) and prevalence of obesity higher among boys compared to girls.
Furthermore, rates of obesity were greater among urban children (12.1%) compared to those from the rural area (11.2%).
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The gut microbiome is the most diverse human microbiome, consisting of thousands of bacterial species. The human
gut microbiome is comprised largely of strict anaerobes and
facultative anaerobes, which are generally discussed at
the phylum level of taxonomic rank. To date, more than
50 bacterial phyla expressing approximately 3.3 million
prokaryotic genes have been identified. However, prior work
has shown, the gut microbiome is largely dominated by 3
phyla, Bacteroidetes (Porphyromonas, Prevotella), Firmicutes
(Ruminococcus, Clostridium, and Eubacteria), and Actinobacteria
(Bifidobacterium).5 This gut microbiota interact with one
another as well as with the host, impacting the host’s physiology and health. Among the significant roles played by the gut
microbiota in humans are vitamin synthesis, digestion
improvement, nutrient and mineral absorption, angiogenesis
promotion, production of short-chain fatty acids (SCFAs),
and nervous system function. The by-products of fermentation such as acetate, propionate, and butyrate are vital for the
gastrointestinal tract (GIT), provide energy for epithelial cells,
enhance the epithelial barrier integrity, and provide immunomodulation and protection against pathogens.6 Recent
studies have investigated the bacterial gene function and its
potential role in human health and metabolism.7 The alteration of the gut microbiota components or dysbiosis has also
been shown to lead to various diseases such as inflammatory
bowel disease, cardiovascular disease, and even cancer.8
Alteration of the gut microbiome is initiated by various factors including diet, medications, stress, obesity, environment
and comorbid diseases such as heart disease or diabetes.
Current evidence supports a link between obesity and composition of the gut microbiota. In contrast, probiotic administration containing the genus Lactobacillus has led to significant
differences in microbial community composition, a reduced
Firmicutes: Bacteroides ratio as well as an increased abundance
of Verrucomicrobia.9
Probiotics have been proven to influence glucose and fat
metabolism, reduce body weight, and improve insulin sensitivity. Hence, it has the potential of a dietary intervention to treat
obesity.10 The effects of probiotics are mostly established for
the Lactobacillus and Bifidobacterium strains in Western cultures, but there is very limited information available from the
Asia-Pacific region.11 Due to the diverse epidemiological
health system and socio-economic conditions, there is a growing need to explore the association between gut microbiota and
obesity in this geographical region. This pilot study was conducted to identify the intervention effect of a probiotics drink
on the alteration of gut microflora among normal and overweight school children from Selangor, Malaysia.

Methods
Study design
Study approval was obtained from the Ethics Committee for
Research Involving Human Subjects Universiti Putra Malaysia

( JKEUPM), Malaysia [FPSK_November (13) 03], Ministry of
Education (MOE), Putrajaya [KP(BPPDP)603/5/JLD.16(154)]
and Department of Education of Selangor, Shah Alam ( JPNS.
PPN 600-1/49 JLD.32(32)]. The study was a randomized and
cross-over design with 2 phases. Each phase lasted 4 weeks with
a 4-week wash-out period in between to prevent carry-over
effects from the previous treatment. All the procedures were carried out following the Helsinki Declaration of 1975, revised in
2008. Consent was obtained from all the subjects who met the
inclusion and exclusion criteria of the study.

Study population
This study included school children from a government school in
Selangor. The subjects were recruited in 2 different groups,
namely normal weight, and overweight. To meet inclusion criteria for the study a participant had to be Malaysian, a registered
student, and aged 7 to 10 years old. Z-scores for BMI-for-age of
−2.0 SD to +1.0 SD were designated as normal weight and more
than +2 SD was designated as overweight. Exclusion criteria
included vaccination within 1 month of the study start, antibiotic
treatments 2 weeks before sample collection, and subjects currently taking probiotics supplements. A total of thirty-seven (37)
subjects comprised of seventeen normal weight and 20 overweight children were enrolled in the study, with thirty-five (35)
completing the study. One normal weight participant and 1 overweight participant were unable to collect all samples and were
thus excluded from analyses. Population characteristics and
demographics of the remaining study participants are further
detailed in Table 1. Phase groups were well-balanced between
normal and overweight children, except unequal variance in
weight between normal and overweight participant groups
(F-test for variance, Group 1: P = 0.006, Group 2: P = 0.046).

Probiotics drink
The probiotic drinks were bottles of Lactobacillus fermented
milk (LcS) containing glucose, fructose, maltitol, and skimmed
milk powder. The components of each 80 ml bottle were energy,
46 kcal; protein, 0.9 g; fats, 0 g; carbohydrates, 10.6 g; sugar,
7.6 g; and dietary fiber, 0.2 g, and approximately 3.0 × 1010
colony-forming units (CFU) of LcS.

Study protocol
Subjects were separated into 2 groups, normal weight, and
overweight. They were further divided into intervention and
control groups. During the first 4 weeks, the phase 1 intervention group received LcS probiotic drinks for daily consumption
while the control groups continued their typical diet. This was
followed by 4 weeks of wash-out period. After, we conducted a
cross-over, where subjects who were not provided the probiotic
drinks in phase 1 were given LcS probiotic drinks and viceversa. The intervention period continued for another 4 weeks

P-values less than 0.05 were considered significant and are shown in boldface. The only significant characteristic appears to be the amount of variance in weight between normal weight and overweight children in both phases.

f-test, 0.149
46.2 (13.5)
36.5 (6.6)
50.1 (6.4)
Daily protein intake, median in g (IQR)

f-test, 0.711

1422 (495)
1002 (307)
1317 (152)
Daily caloric intake, median in Kcal (IQR)

48.1 (18.1)

9 (90.0)
5 (55.6)
8 (88.9)
6 (85.7)
Malay

f-test, 0.061

1 (10.0)
2 (22.2)
1 (11.1)
0 (0.0)
Indian

0 (0.0)
1 (14.2)
Bumiputera Sarawak

1420 (525)

0 (0.0)
0 (0.0)

f-test, 0.175

Fisher’s Exact Test, 0.275
0 (0.0)
0 (0.0)
Race, n (%)

Bumiputera Sabah

0 (0.0)

Fisher’s Exact Test, 0.7

2 (22.2)

f-test, 0.046
46.9 (18.0)
f-test, 0.006
Weight, median kg (IQR)

26.9 (3.25)

48.2 (16.8)

32.3 (13.1)

t-test, 0.529
9 (1.75)
9 (2)
t-test, 0.128
9 (0)
8 (1.5)
Age, median (IQR)

Fisher’s Exact Test, 0.170
4:6 (40.0, 60.0)
7:2 (77.8, 22.2)
Fisher’s Exact Test, 0.901
4:5 (44.4, 55.6)
3:4 (42.9, 57.1)
Female:Male, n (%)

Chi-sq, 0.819
n = 10
n=9
Chi-sq, 0.617
n=7

n=9

Overweight
P-value

Normal

P-value

3

Overweight
Normal

Phase 2
Phase 1

Table1. Population characteristics table within each intervention phase group. P-values were obtained by tests described in the table, looking for distinctions between normal weight and overweight
children within each phase group.
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and is referred to as phase 2. Throughout the intervention
study, subjects were required to consume a common diet as
other Malaysian children and continue their routine physical
activities.12

Fecal sample collection and DNA extraction
Fecal samples were collected from the subjects at week 0, week
5, week 10, and week 15. The flow of the study design indicating the study duration, probiotic consumption, and sample collection can be seen in Figure 1. Approximately 1 g feces were
collected from the subjects at each time point using a sterile
fecal collection tube and stored at −80°C for further processing.
Approximately 200 mg of the fecal samples were mixed with
1 ml InhibitEX Buffer in a 2 ml microcentrifuge tube and vortexed thoroughly to homogenize the sample. DNA was
extracted using QIAamp® Fast DNA Stool Mini kit per the
manufacturer’s instructions.13 The DNA was eluted using 200
uL elution buffer (0.1 mM EDTA, 10 mM Tris-HCl, 0.1%
sodium azide, pH 8.0) and was stored at −20°C prior to
sequencing. The concentration and purity of the extracted
DNA were determined using Nanodrop 1000 v3.7.1 (Thermo
Fisher Scientific, Massachusetts, U.S).

DNA amplification and sequencing
The V3-V4 region of 16S rRNA gene was amplified using forward primer (5’–TCGTCGGCAGCGTCAGATGTGTA
TAAGAGACAGCCTACGGGNGGCWGCAG–3’) and
reverse primer (5’–GTCTCGTGGGCTCGGAGATGT
G TATA A G A G A C A G G A C TA C H V G G G TAT C
TAATCC–3’). These primers contain partial Illumina Nextera
adapter. The pooled libraries were then quantified, denatured
and sequenced on Illumina MiSeq platform.14,15

Sequence data analysis and OTU table construction
Raw FASTQ files were quality controlled using the pipeline
SHI7.16 Nextera sequencing adapters were removed and all
sequences trimmed until a threshold average quality score of
>35 was achieved. Sequences not meeting these criteria were
omitted. We performed Operational Taxonomic Unit (OTU)
picking on the remaining samples with the exhaustive optimal
alignment software BURST against the GreenGenes (version
13_8) database clustered at 97% identity.17 In total, 88.8% of
quality-controlled reads were assigned to an OTU for downstream analyses. The resulting OTU and taxonomy tables were
then filtered using the statistical software R to remove singletons and OTUs of extremely low confidence (<0.01% average
sample relative abundance). Before performing differential
taxon abundance analyses, OTU and taxonomy tables were rarefied to a depth of 4018 reads and 4068 reads, respectively, as
well as transformed using a centered log-ratio (CLR) transform, thus eliminating the need for a reference value in the
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Figure 1. Cross-over study design. In the first 4 weeks, the phase 1 intervention groups received LcS probiotic drinks for daily consumption while the
control groups continued their typical diet. This was followed by 4 weeks of wash-out period. Later, there was a cross-over, where subjects who were not
provided the probiotic drinks before were given LcS probiotic drinks and vice-versa. The intervention period continued for another 4 weeks and subjects
participating in this later probiotics intervention are referred to as “phase 2.”
***INTERVENTION = Probiotic administration in the past 4 weeks lapse.
Control = No probiotic administration from past 4 weeks.

creation of normalized, per-sample relative abundance tables.
Custom analyses in R were created for computing diversity
measures, conducting statistical tests, and generating figures
using the vegan, ape, phyloseq, and ggplot2 packages.18-21 In
statistical tests, all associations producing an FDR-adjusted
P-value < 0.05 were considered significant.

Results
Probiotic intervention effect on alpha diversity
Alpha diversity, within sample diversity, was quantified using
the Shannon diversity index, incorporating both OTU richness
and evenness. A higher Shannon index is indicative of greater
species diversity within a sample. To specifically identify the
probiotic intervention impact on alpha diversity, intervention
impact was defined as the change in Shannon diversity index
per individual during their intervention period, subtracting the
prior-to-intervention sample Shannon index value from the

post-intervention sample value. An unpaired t-test revealed no
significant difference between weight statuses in terms of this
intervention impact (Figure 2). However, a greater percentage
of normal weight individuals exhibited a positive intervention
effect (68.75%) compared to overweight individuals (57.89%),
implying children in the normal weight category more commonly experienced greater alpha diversity following a probiotics intervention.

Probiotic intervention effect on beta diversity
We evaluated differences between bacterial communities using
weighted UniFrac distance, incorporating phylogenetic relatedness, of all present OTUs after rarefaction. We stratified beta
diversity analyses by phase groups, where phase 1 received the
probiotic intervention prior to the week 5 sample and phase 2
conducted their intervention phase prior to week 15. Within
each phase, we evaluated the impact of the week category, to

Joseph et al
see if there was a temporal effect on microbial composition.
Interestingly, we found a significant temporal effect in phase 1
(Mann–Whitney U test, P < 0.05) but not phase 2. This is

Figure 2. The intervention effect on alpha diversity measured using
Shannon diversity Index plot for normal weight (orange) and overweight
(blue) children. A higher Shannon Index implies greater alpha diversity,
both in terms of OTU richness and evenness. The median is represented
by the line inside the box, while the lowest and the highest values within
the 1.5 interquartile range (IQR) are represented by the whiskers. The
individual sample values including outliers are shown as points over the
boxes. An unpaired t-test showed no significant difference in intervention
effect between weight status groups (P = 0.164).

5

indicative of a shift induced by intervention and prolonged in
the weeks following, as the significant impact of time is only
seen in the group with the earlier intervention. In order to
determine an explicit intervention impact, we further separated
analyses into 2 sets of samples regardless of phase, before an
intervention period and immediately after the intervention
period. Without the baseline reference groups, significance of
the intervention impact on microbial profile was lost. To visualize these analyses, we conducted Principal Coordinates
Analysis (PCoA) on each phase, illustrating the 95% confidence interval of each set of samples with ellipses (Figure 3A).
To further investigate the impact of our probiotics intervention as well as weight status, we conducted redundancy analysis
(RDA) on the CLR -transformed OTU tables using the RDA
function in the R vegan package. The RDA stratified by phase
once again and constrained for weight and probiotics intervention as well as other suspected confounding variables such as
age, gender, and week of sample collection. After comparing
these constraints to an unconstrained RDA, we were able to
determine the adjusted R-squared and proportion of variance
explained by each variable in the constrained RDA for phase 1
(Table 2A) and phase 2 (Table 2B), respectively. Significance of
each variable in determining RDA distance was evaluated using
the env.fit function in the vegan package in R. Remaining consistent with our findings with weighted UniFrac and PCoA, we
found an intervention effect was only significant within the first
phase (PERMANOVA, P-value < 0.05). Using the same subset
of samples from looking for weighted UniFrac intervention

Figure 3. Principal coordinates analysis (PCoA) using weighted UniFrac distances across all present OTUs within each phase and then combining
phases but showing only the samples taken immediately before and after the probiotics intervention in each phase (A). Only phase 1 showed a significant
relationship with weeks (PERMANOVA, P < 0.05). Using the same subsets of samples, a constrained RDA is shown below each PCoA plot, annotated
with arrows to indicate the direction of significant variables in the RDA ordination space. Points in all figures represent samples, where more similar
samples appear closer together.
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Table 2. Permutational Analysis of Variance (PERMANOVA) on RDA
constraints in phase 1 (A). and phase 2 (B) populations. “Prop. Var.
Explained” is a percentage of unconstrained RDA variance explained
by each variable.
A
Variable

R-squared

Prop. Var.
Explained (%)

P-value

Week

0.392

4.34

0.01**

Weight

0.246

3.05

0.01**

Age

0.130

3.79

0.02*

After Prob.

0.257

5.64

0.01**

Female

0.040

3.44

0.108

Overweight

0.003

2.21

0.841

Variable

R-squared

Prop. Var.
Explained (%)

P-value

Week

0.390

3.41

0.01**

Weight

0.266

4.11

0.01**

Age

0.068

2.66

0.118

After Prob.

0.039

1.25

0.089

Female

0.040

3.05

0.040*

Overweight

0.024

2.44

0.242

B

P-values < 0.05 were considered significant and are shown in boldface.
*P < 0.05, **P < 0.01.

effects within both phases, we found significance in terms of
constrained RDA variation (PERMANOVA, P = 0.01). This
could be because the constraints in RDA restricted the variation
explained on each axis to severely less than PCoA, as represented by the percentages of variance listed alongside each axis
(Figure 3B). So, the intervention effects appear to have significantly impacted only a small proportion of what we know as the
microbial profile of our samples.
The probiotics intervention impact is further illustrated by
looking at shifts within subjects. Stratifying by weight status,
we plotted the samples before and after probiotics intervention
per subject, connecting samples from the same subject by coloring them alike and drawing an arrow indicating before to
after effect (Figure 4). The high variance across individuals
regardless of phase and weight status implies probiotics intervention effects may be strongly confounded with high subjectto-subject variance and low sample size in this pilot study.

Relative abundance of the most prevalent bacteria
at varying taxonomic ranks
Genus-level taxonomic profiling of normal and overweight
subjects revealed varied changes in bacterial relative abundance

with probiotic intervention (Figure 5). Normalized for relative
abundance taxonomic tables were collapsed to various taxonomic ranks, namely phylum, family, genus, and species. Each
taxonomic rank table was evaluated per taxon for association
with the probiotic intervention using a Mann–Whitney U test
(P-values < 0.05 considered significant). Significant taxon
shifts observed across all samples as well as after stratifying by
normal and overweight weight status were retained for generation of a bar plot describing the number of significantly
impacted taxa after probiotics intervention (Figure 6).
Among the taxa significantly impacted by the intervention
period, we decided to look closer at the difference in this impact
between normal and overweight individuals. For instance, at
the family level, overweight subjects were significantly depleted
of Bacteroidaceae while normal subjects experienced a significant increase in Bacteroides after probiotics intervention (Figure
7A). A closer inspection of the species Bacteroides ovatus, an
anaerobic gram-negative bacteria from the phylum Bacteroidetes,
revealed a similar significant discrepancy between normal and
overweight subjects (Figure 7B), likely contributing to the distinction seen in the Bacteroidaceae family. The Lachnospira
genus was also found to be significantly impacted by intervention, but there was no significant relationship to weight status
in this change (Figure 7C).

Phylogenetic diversity among normal and
overweight children microbiomes
The heatmap (Figure 8) demonstrates the increase or decrease
of all microbes specified at the phylum level in individuals after
the probiotics intervention. Among all the phyla found, none
showed a significant difference after intervention. The distinction between normal and overweight individuals is minimal,
phylum-specific differences between the weight statuses were
not found. So, we generated another heatmap describing taxa
at the genus level after the probiotics intervention (Figure 9).
Only genera showing a significant change (P < 0.05) across all
individuals during intervention are displayed, hierarchically
clustered according to their correlation with the intervention.
Positively correlated genera with intervention are shown in
blue, largely from the Bacteroidetes (Bacteroides, Alistipes,
Odoribacter) and Firmicutes (Oscillospira, Lachnospira) phyla
despite the lack of significance in intervention found in those
phyla overall. Meanwhile, genera in the Proteobacteria
(Acinetobacter, Pseudomonas, Proteus) phylum appeared to significantly decrease with the probiotics intervention.

Discussion

Obesity has grown as an emerging public health problem
worldwide aﬀecting more than 24% children and adolescents.22
Studies have demonstrated there are at least 18 co-morbidities
that are attributed to overweight status and obesity including
type 2 diabetes mellitus, cardiovascular diseases, Alzheimer’s
disease, and cancer.23,24 Recent studies indicate that probiotics

Joseph et al
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Figure 4. Principal coordinates analysis (PCoA) using weighted UniFrac distance displaying all individuals, stratified by weight status. Only samples
immediately prior to and after the probiotic drink intervention are displayed, connected by an arrow indicating the direction of movement from before
intervention to after intervention.

Figure 5. Changes in the relative abundance of taxa at the genus level before intervention and after intervention, per subject. Only the first 14 most
abundant genera overall are named, others are summed up into an “Other” category.

species play significant roles in sustaining the gut microbiota
ecosystem in humans and help prevent obesity. Various studies
investigated the association between obesity and the composition of the gut microbiota. This study was our first attempt to
understand the impact of probiotics consumption on the gut
microbiome diversity in normal and overweight children from
Malaysia, a previously underrepresented group in microbiome
literature.
Our results show that probiotic consumption (intervention)
has led to different microbial alterations among normal-weight
children compared to overweight children. Many studies have
reported a lower alpha diversity in obese compared to normalweight humans, but we found probiotics intervention did not
significantly impact alpha diversity in 1 weight status group over
the other.25-27 Rather, our pilot study found distinctions between

Figure 6. A bar chart indicating the number of taxa at varying taxonomic
levels found to be significantly impacted by the probiotics intervention,
regardless of weight status or another confounding variable. Significance
was evaluated by a Mann–Whitney U test per taxon, with P-values < 0.05
considered significant.
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Figure 7. A closer look at taxa significantly impacted by intervention phases. In these plots, purple indicates a positive impact, orange indicates a
negative impact. The family Bacteroidaceae (A) showed a significant difference between normal weight and overweight children in terms of intervention
impact on the taxon (Mann–Whitney U test, P = 0.031). Within the Bacteroidaceae family is the Bacteroides ovatus species (B), which showed a similar
significant distinction between weight statuses (Mann–Whitney U test, P = 0.017). However, not all taxa significantly impacted by the intervention were
necessarily distinct in their intervention impact between weight statuses, as shown by the Lachnospira genus (Mann–Whitney U test, P = 0.12).

Figure 8. Heatmap demonstrating the increase or decrease of microbes at the phylum level in individuals during the probiotics intervention phase. Blue
indicates an increase in that phylum while red indicates a decrease in relative abundance.

Figure 9. Heatmap demonstrating the increase or decrease of microbes at the genus level in individuals during the probiotics intervention phase. Blue
indicates an increase in that phylum while red indicates a decrease in relative abundance.

weight statuses were primarily concentrated in overall microbial
composition, where the probiotic drink had differing impacts on
the child’s specific gut microbes depending on weight status.
Beta diversity analyses revealed the intervention may have
caused perturbations in all the participants’ microbiomes.
PCoA analysis per individual suggests that the populations’
microbiomes varied throughout the study, but significant
impacts of intervention were sustained in the phase 1 group
drinking the probiotic earlier in the study according to both

weighted UniFrac measures and RDA. Constrained RDA
revealed a significant impact of weight status on a smaller proportion of variance than described in weighted UniFrac and
PCoA, but implies there are weight status distinctions among
less influential taxa. The results are consistent with a study
reported by Lin et al (2015) where a significantly distinct beta
diversity was observed in obese individuals compared to that of
normal weight.28 Conversely, there are studies reporting an
unchanged beta diversity between similar groups, so there is

Joseph et al
more work to be done with larger studies in a variety of geographic populations.29,30
Considering the relatively small proportion of variance in
gut bacterial composition explained in our constrained RDA,
we could presume that the effects on alpha and beta diversities
differ according to various confounding factors not included in
our analysis such as diet, physical activity, and geographical
location of the participants’ homes.31 We believe inconsistencies in literature and our findings may be results of the complex
relationships between environmental, genetic, diet or clinical
factors.32,33 We also believe our population size and study
design limited our exploration of overall bacterial composition,
as the sample sizes were too small to overcome individual bias
in many instances of analysis.
Analysis of the bacterial community at the species level found
that the proportions of Bacteroides ovatus, an anaerobic, gramnegative bacteria from the Bacteroides genus commonly found in
the gut was markedly increased in normal-weight children but
depleted in overweight children after the probiotics intervention.
This is in agreement with other similar studies that reported an
increase in bacterial species from the phylum Bacteroidetes in lean
individuals. There was an increase in the bacterial species such as
Bacteroides thetaiotaomicron and Bacteroides faecichinchillae from
Bacteroides phylum and Blautia wexlerae, Clostridium bolteae, and
Flavonifractor plautii species from the Firmicutes phylum among
lean individuals. On the other hand, obese individuals had a
larger composition on bacterial species belonging to the
Firmicutes phylum such as Blautia hydrogenotorophica, Coprococcus
catus, Eubacterium ventriosum, Ruminococcus bromii, and
Ruminococcus obeum.3,34-37 These findings support the association
of obesity with bacterial species from the Firmicutes and
Bacteroidetes phyla. Future studies should focus on directly targeting theses phyla to differentiate weight status.
Finally, at genus level comparisons, Lachnospira and
Ruminococcus were found to increase among overweight participants compared to normal weight participants. These findings, however, contradict previous studies. Previous studies
have demonstrated that Ruminococcaceae and Lachnospiraceae
are associated with SCFAs production and these genera were
found to be depleted in overweight individuals compared to
lean individuals.38,39
Our findings imply microbial dysbiosis is not a discriminative
feature to distinguish overweight and normal-weight individuals. Rather, our results imply microbial composition can be successfully altered in either weight status with probiotics, but these
alterations may be distinct between overweight and normalweight children at various taxonomic ranks. The major limitations of our pilot study are the short intervention period and
population size. A longer period of intervention could help us
more precisely identify the effects of probiotics on the Malaysian
child gut microbiome. Confounding factors such as physical
activity and diet could also be better reported to identify their
impact on probiotics and gut microbiota in both normal and
overweight children.40
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Overall, our probiotics intervention was found to have
numerous impacts across the participants regardless of weight
status or intervention period, implying that the microbiome
can be altered with probiotics with a significant chance of success. Yet, there is limited evidence supporting a distinct microbiome composition in overweight children as compared to
normal-weight children following probiotics. This pilot study
provides a framework for future research to study the effect of
probiotics intervention on the gut microbiota profile.
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